Delivery Order SPE2DR25D3102-SPE2DR26F2P4M
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Entecavir 0.5 mg tablets (30-count) valued at $2,795.02, with completion scheduled for November 13, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The performance location is the company's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $2,832.16 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Entecavir 0.5 mg tablets in a 30-count package. This is a firm fixed-price, non-set-aside contract with a completion date of July 22, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,996.61 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Entecavir 0.5 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, consistent with AmerisourceBergen's typical federal procurement profile....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Entecavir 0.5 mg tablets (30-count packages) with a ceiling value of $1,442.99. This is a firm fixed price delivery order with an ultimate completion date of December 9, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,516.79 delivery order to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by June 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1.80K to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count) with a completion date of October 23, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and identifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $23,536.24 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count units) under a firm fixed-price contract structure. The award, issued on December 1, 2025, with an ultimate completion date of December 2, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its...
- The Defense Logistics Agency awarded a $2,275.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count) with an ultimate completion date of June 3, 2025. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Entecavir 0.5 mg tablets in quantities of 30 units, with a ceiling value of $3,924.11 and a completion date of December 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and is performed at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Entecavir 0.5 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $6,625.21 and an ultimate completion date of May 9, 2025. The contract is not set-aside and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- SPE2DR25D3102Indefinite Delivery Contract
- SPE2DR25D3102-SPE2DR26F2P4MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Entecavir 0.5 mg tablets (30-count) with a contract value of $1,267.02 and an ultimate completion date of December 12, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen serves as a prime pharmaceutical vendor for the Defense Logistics Agency, supplying a comprehensive range of medications and medical supplies to support military and federal healthcare systems worldwide. The company's contract portfolio demonstrates consistent capability in fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains for defense and civilian federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/10/25 |